<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Mood Disorders</title>
    <style>
        body {
            background-color: #B9F3E4;
        }
        hr {
            border-style: dotted;
            border-color: rgb(149, 216, 214);
            border-width: 8px;
            width: 8%;
            background-color: #B9F3E4;
            border-bottom: none;

        }
    </style>
</head>
<body>
    <h1>Pharmacology of Mood Disorders</h1>
    <hr size="3" noshade>
    <h6><a href="index.html">Return</a></h6>
    <br>
    
    <!--Lithium-->
    <h3>Lithium</h3>
    <p>
        Salts: Carbonate/Citrate. 1597mg Li2co3 has 300mg elemental Li.
        Levels: 0.6-1.2 mEq/L. Dosing - 600-900 in divided doses. Not metabolised. Only renal excretion. 
        T1/2 about 24 hours. T/eq-5-7 days
    </p>
    <p>
        Excreted in Breast milk. A/w <a href="https://medlineplus.gov/ency/article/007321.htm">Ebstein's anomaly.</a> (First trimester mostly)
    </p>
    <p>
        S/E: Renal- Polyurea with secondary polydipsia(25-35% - use K sparing diuretics like spironolactone, amiloride). Non Specific Interstitial Fibrosis- decreased GFR. Have to do RFT -6 months.
    </p>
    <p>
        S/E: Thyroid:Goitre(in 5%), Hypothyroidism(7-10%). TFT - 6monthly. 
    </p>
    <p>
        S/E: Neurological: Postural tremors(8-12 Hz). Toxicity: Coarse tremors, dysarthria, ataxia, impaired consciousness, fasciculations, myoclonus, Sz, coma. Sometimes Cognitive dulling. 
    </p>
    <p>
        S/E: Skin - maculopapular rash, worsening psoriasis, alopecia. Cardiac - Mostly benign - hypokalemia like. Some wt gain.
    </p>
    <p>
        <strong>Lithosun, Licab.</strong>  About Rs 20 / 10 tablets.
    </p>
    <br>
    <hr>

    <br>

    <!--Valproate-->
    <h3>Valproate</h3>
    <p>
        Formulations: Valproic acid, Divalproex Na: 1:1 of valproic acid and sodium valproate, Na Valproate Injection. Antimanic conc: 50-150 microg/ml. Dosage:oral- 20-30mg/kg/day. 1200-1500mg/day
    </p>
    <p>
        t1/2: 10-16 hours. Favourable thyroid and renal profile. Metab by hepatic. Starts acting within 1-4 days. Better than Li for irritable mania, children, elderly, rapid cycling. Better for agitation than dysphoria.
    </p>
    <p>
        S/E: <strong>HATS-P</strong>: Hepatotoxicity, Hyperammonimea, A/w Urea Cycle, Teratogenicity- Neural Tube Defect, Thrombocytopenia, Somnolence in Elderly, Pancreatitis.
    </p>
    <p>
        S/E: Wt gain, Alopecia, PCOS(atleast 33%), moderate hyponatremia.
    </p>
    <p>
        <strong>Torvate(300) </strong> about INR 30/10tabs. <strong>Dicorate, Divaa</strong> about INR 150-200/10 tabs of 500mg each
    </p> <br>
    <hr>
    <br>

    <!--Lamotrigine-->
    <h3>Lamotrigine</h3>
    <p>
        Stabilising BPAD from below. Not very effective in mania.T1/2-25hours. Excreted in urine. Dose: 100-200 mg/day. Relatively safe in pregnancy/lactation. MOA: voltage sensitive Na -
    </p>
    <p>
        monothrapy: 25mg/2 weeks increase to 100-200. With CBZ 50mg/2weeks. With Valproate- 25mg/4weeks.
    </p>
    <p>
        Weak 5HT3-, serotonin reuptake inhibitor, modulates release of glutamate and aspertate. Lengthening span b/w depressive episode.
    </p>
    <p>
        S/E: Relatively well tolerated(lacks sedation/wt gain/metabolic). Benign maculopapular rash(8%). SJS/TEN in 0.1%
    </p>
    <p>
        Drug interactions: Valproate doubles plasma lvl. Lamotrigine decreases Valproic acid. Decreased conc with CBZ,phenytoin, phenobarbital.
    </p> <br>
    <hr>
    <br>

    <!--CBZ and OxC-->
    <h3>CBZ and Oxcarbazepine</h3>
    <p>
        Second line. OxC is analogue of CBZ. T1/2 CBZ- 18-54hrs. Chronic-autoinduction.T1/2-12hrs. Metabolized in liver. MOA- VDSC,NMDA receptors, Alpha1-, VDCC. Mostly used in acute mania.
    </p>
    <p>
        S/E: Well tolerated(no wt gain). Serious s/e- blood dyscrasias(aplastic anaemia, agranulocytosis) - routene hemat monitoring 3,6,9,12 months.
    </p>
    <p>
        S/E: Maculopapular rashes(rare SJS/TEN). Neural Tube defect in pregnancy. Secreted in breast milk. Drug interactions- many CYP3A4 induction.
    </p>
    <p>
        Antimanic dose: 1200mg/day. anticonvulsant conc: 4-12microg/ml. Oxcarb has increased risk of hyponatremis(3-5%). Less risk of blood dyscrasias and rashes.
    </p>
    <p>
        T1/2 OxC - 9-12 hrs. Dose range - 150-2400 mg/day. B/D dosing.
    </p>


</body>
</html>
